Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Dr Cole Seifert, PhD
Research Manager at Croda Pharma
Speaker

Profile

Dr. Cole Seifert obtained his Bachelor’s and PhD in Chemistry from Texas Tech University. During his PhD research, Dr. Seifert invented Group-Assisted Purification (GAP) Peptide Synthesis Technology and secured investment to commercialize the technology via the startup company, GAP Peptides, LLC. From 2017 – 2022 he served as GAP Peptides’ President and Chief Scientific Officer, and led the development of scalable, sustainable methods for peptide and biopolymer synthesis. Following acquisition of GAP Technology by Croda, Inc. in 2022, Dr. Seifert now leads peptide development activities at Croda.

Agenda Sessions

  • Optimizing GAP Peptide Synthesis for Tirzepatide Fragments

    , 11:10am
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Cole at TIDES USA: Oligonucleotide & Peptide Therapeutics